dr. herbst on immuno-oncology combinations in lung cancer
Published 4 years ago • 307 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:03
dr. herbst on combination therapies for lung cancer
-
1:22
dr. herbst on immune resistance in lung cancer
-
1:35
dr. herbst on promising immunotherapy combinations in nsclc
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
5:10
immuno-oncology combination therapy in nsclc
-
2:17
breakthrough lung cancer drug to be added to the pbs
-
3:46
understanding immunotherapy for lung cancer
-
4:48
what is immunotherapy and how does it work for lung cancer?
-
1:56
dr. herbst on advances of immunotherapy in lung cancer
-
2:15
dr. herbst on the next generation of lung cancer trials
-
0:58
dr. herbst on immunotherapy in lung cancer
-
1:00
dr. herbst discusses immunotherapy in lung cancer
-
1:49
dr. herbst on the impact of frontline immunotherapy in lung cancer
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
1:20
dr. herbst discusses new immunotherapy agents for lung cancer
-
1:18
dr. herbst on next-generation agents in nsclc
-
1:09
dr. herbst on the bevacizumab biosimilar in lung cancer
-
7:16
immuno-oncology combination therapy: which patients with nsclc?
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
1:42
dr. herbst on tmb as a biomarker in nsclc
-
1:02
dr. herbst on pd-1 inhibitors in lung cancer
-
1:23
dr. herbst on themes from the 2011 lung cancer congress